It's important for us all to remember that we have been following this company for years and we all either saw or by now know what happened in the presentation.
Everyone else is just seeing headlines from cancerconnect and aacr that DCVax-L failed.
We're clearly in a horrible spot and until management gets word out FOR F'ING ONCE, we're going to be dealing with a bunch of raids on the stock.
I, for one, am holding and giving them a bit more time. But if they don't do a lot by ASCO and at ASCO, we're going to be back down below 30 cents. After sitting in front of a bloomberg and watching action for 8 years, I can guarantee that.
We need to keep the pressure on management to take action.
I'm doing so, I'm not just saying so. I sent this after the presentation to Dave, Les and Linda. I know they saw it because Linda has responded to all of my emails over the years.
"Hi Dave-
You probably don’t know me well because I try to leave you guys alone, we’ve conversed electronically a time or two a long time ago. I have 730,000 shares personally and am responsible for about 1.2 million shares amongst my friends and family. I didn’t sell any today and I’ve been accumulating for 8 years. I’m most definitely one of your “die-hards”. But, being in this business, I gotta say you guys really dropped the ball not halting the stock pre-talk. That would have set the psychological mindset that the data was earth-shattering. We would not have seen what we saw today. It also should have been done so everyone could get the same data disseminated at the same time. I have no idea why it wasn’t.
The real point of emailing today is I sure hope there’s more up the sleeve than just the paper coming out. That ain’t gonna cut it breaking this stranglehold the market aholes have on us.
I’m truly, very much appreciative of everyone’s hard work. I’m frustrated, but alas I wait longer. I’m used to it."
Note, I know the word from management is they weren't allowed to halt the stock. They clearly didn't explain to FINRA what was happening properly. I know they published the full slide deck right away on virtualtrials, but without a PR announcing the data, they didn't disseminate the information to everyone fairly. That is another misstep by management and I believe it's the one that cost us a large chuck of the prior appreciation of price.
